Unicycive Therapeutics (UNCY)

OLC Resubmission Accepted For FDA Review


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
January 30, 2026
Report ID: 28020
Already Registered?
Click the Get Report button to login and view the full report, with price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Register Now to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc.
Biotechnology
Healthcare
Ticker
UNCY
Current Price
$6.0469 -9.34%
Market Cap
$130.0M
Price Target
Refer to Report
Volume
723.0K
52wk Range
$3.71 - $11
© 2018-2026 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.